Lumonus is a healthcare company that offers Radiation Oncology, Radiation Therapy, and Cancer treatment technology-enabled services.
Lumonus has raised $16.3M in total funding. The most recent round was Series B. The last funding was announced in November 2025.
Lumonus's investors include Oncology Ventures, Aviron Investment Management.
Lumonus is headquartered in North Sydney, Australia.
Lumonus is a healthcare company that offers Radiation Oncology, Radiation Therapy, and Cancer treatment technology-enabled services.
Lumonus is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lumonus — Funding & Investors." VCBacked, November 6, 2025, https://www.vcbacked.co/company/lumonus. Accessed October 17, 2026.
VCBacked. (2025). Lumonus — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/lumonus
{{cite web |title=Lumonus — Funding & Investors |url=https://www.vcbacked.co/company/lumonus |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated